Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants

NCT05738850 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder (GAD)
Healthy Participants

Interventions

DRUG: ABBV-932
DRUG: Placebo

Sponsor

AbbVie

Collaborators

[object Object]